Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Clinical trial NCT01327612 · COMPLETED

Trial details

NCT number: NCT01327612
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Carcinoid Colorectal Cancer Locally Advanced Lymphoma Metastatic Cancer Non-Small Cell Lung Cancer Sarcoma Solid Tumors

Start date: 2011-03-03
Primary completion: 2020-02-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.